...
首页> 外文期刊>Journal of Computer-Aided Molecular Design >ALOHA: A novel probability fusion approach for scoring multi-parameter drug-likeness during the lead optimization stage of drug discovery
【24h】

ALOHA: A novel probability fusion approach for scoring multi-parameter drug-likeness during the lead optimization stage of drug discovery

机译:ALOHA:一种新的概率融合方法,用于在药物发现的前导优化阶段对多参数药物相似性进行评分

获取原文
获取原文并翻译 | 示例
           

摘要

Automated lead optimization helper application (ALOHA) is a novel fitness scoring approach for small molecule lead optimization. ALOHA employs a series of generalized Bayesian models trained from public and proprietary pharmacokinetic, absorption, distribution, metabolism, and excretion, and toxicology data to determine regions of chemical space that are likely to have excellent drug-like properties. The input to ALOHA is a list of molecules, and the output is a set of individual probabilities as well as an overall probability that each of the molecules will pass a panel of user selected assays. In addition to providing a summary of how and when to apply ALOHA, this paper will discuss the validation of ALOHA's Bayesian models and probability fusion approach. Most notably, ALOHA is demonstrated to discriminate between members of the same chemical series with strong statistical significance, suggesting that ALOHA can be used effectively to select compound candidates for synthesis and progression at the lead optimization stage of drug discovery.
机译:自动化的铅优化助手应用程序(ALOHA)是一种用于小分子铅优化的新颖健身评分方法。 ALOHA采用了一系列通用的贝叶斯模型,这些模型是根据公开和专有的药代动力学,吸收,分布,代谢和排泄以及毒理学数据进行训练的,以确定可能具有出色的类药物特性的化学空间区域。 ALOHA的输入是分子列表,输出是一组单独的概率以及每个分子将通过一组用户选择的测定的总体概率。除了提供有关如何以及何时应用ALOHA的摘要之外,本文还将讨论ALOHA的贝叶斯模型和概率融合方法的验证。最值得注意的是,已证明ALOHA可以区分具有相同统计学意义的同一化学系列的成员,这表明ALOHA可在药物发现的前期优化阶段有效地用于选择合成和进展的化合物候选物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号